Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Falvella FS"" wg kryterium: Autor


Tytuł:
Reply to La Gioia: effects of cold agglutinins on the automated complete blood count accuracy.
Autorzy:
Falvella FS; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Panteghini M; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Pokaż więcej
Źródło:
Scandinavian journal of clinical and laboratory investigation [Scand J Clin Lab Invest] 2022 Feb; Vol. 82 (1), pp. 68. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji:
Letter; Comment
MeSH Terms:
Cryoglobulins*
Blood Cell Count ; Humans
Opinia redakcyjna
Tytuł:
Prospective validation of an automatic reflex test for identifying spurious elevations of mean corpuscular haemoglobin concentration due to the presence of cold agglutinins.
Autorzy:
Falvella FS; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Chibireva M; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Panteghini M; Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy.
Pokaż więcej
Źródło:
Scandinavian journal of clinical and laboratory investigation [Scand J Clin Lab Invest] 2021 Nov; Vol. 81 (7), pp. 598-600. Date of Electronic Publication: 2021 Aug 04.
Typ publikacji:
Journal Article; Validation Study
MeSH Terms:
Erythrocyte Indices*
Reflex/*physiology
Adult ; Anemia, Hemolytic, Autoimmune/blood ; Cryoglobulins/metabolism ; Erythrocytes/metabolism ; Humans
Czasopismo naukowe
Tytuł:
A Comprehensive Appraisal of Laboratory Biochemistry Tests as Major Predictors of COVID-19 Severity.
Autorzy:
Aloisio E; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).
Chibireva M; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).
Serafini L; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).
Pasqualetti S; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).
Falvella FS; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).
Dolci A; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).; The Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy (Dolci, Panteghini).
Panteghini M; From the Clinical Pathology Unit, ASST Fatebenefratelli-Sacco, Milan, Italy (Aloisio, Chibireva, Serafini, Pasqualetti, Falvella, Dolci, Panteghini).; The Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy (Dolci, Panteghini).
Pokaż więcej
Źródło:
Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2020 Dec 01; Vol. 144 (12), pp. 1457-1464.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Severity of Illness Index*
Biomarkers/*blood
COVID-19/*diagnosis
COVID-19 Testing/*methods
Adolescent ; Adult ; Aged ; Aged, 80 and over ; COVID-19/blood ; COVID-19/mortality ; COVID-19/therapy ; Critical Care ; Female ; Humans ; Italy/epidemiology ; Logistic Models ; Male ; Middle Aged ; Prognosis ; ROC Curve ; Retrospective Studies ; Survival Analysis ; Young Adult
Czasopismo naukowe
Tytuł:
Acute hyperammonemia in children under deferasirox treatment: cutting the Gordian knot.
Autorzy:
Martinelli D; a Division of Metabolism and Research Unit of Metabolic Biochemistry , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.; b Genetics and Rare Diseases Research Division , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.
Goffredo BM; a Division of Metabolism and Research Unit of Metabolic Biochemistry , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.
Falvella FS; c Unit of Clinical Pharmacology, Department of Laboratory Medicine , Milan , Italy.
Marano M; d DEA Paediatric Intensive Care Unit , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.; e Regional Paediatric Poison Center , IRCCS Bambino Gesù Children's Hospital , Rome , Italy.
Pokaż więcej
Źródło:
Clinical toxicology (Philadelphia, Pa.) [Clin Toxicol (Phila)] 2019 May; Vol. 57 (5), pp. 375-377. Date of Electronic Publication: 2018 Nov 16.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Ammonia/*blood
Deferasirox/*adverse effects
Hyperammonemia/*chemically induced
Iron Chelating Agents/*adverse effects
Acute Disease ; Adolescent ; Age Factors ; Biomarkers/blood ; Child, Preschool ; Female ; Humans ; Hyperammonemia/blood ; Hyperammonemia/diagnosis ; Hyperammonemia/therapy ; Male ; Risk Factors
Raport
Tytuł:
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
Autorzy:
Giacomelli A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy. .
Riva A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Falvella FS; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Oreni ML; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Cattaneo D; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Cheli S; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.
Renisi G; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Di Cristo V; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Lupo A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Clementi E; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Unit, Milan, Italy.; E. Medea Scientific Institute, Bosisio Parini, Italy.
Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Galli M; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Ridolfo AL; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Via G.B. Grassi, 74, 20157, Milan, Italy.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2018 Nov 12; Vol. 18 (1), pp. 556. Date of Electronic Publication: 2018 Nov 12.
Typ publikacji:
Journal Article
MeSH Terms:
Chemical and Drug Induced Liver Injury*/epidemiology
Chemical and Drug Induced Liver Injury*/genetics
Anti-HIV Agents/*adverse effects
HIV Infections/*drug therapy
Nevirapine/*adverse effects
Adult ; Anti-HIV Agents/administration & dosage ; Anti-Retroviral Agents/administration & dosage ; Anti-Retroviral Agents/adverse effects ; Drug Therapy, Combination/adverse effects ; Female ; Genetic Predisposition to Disease ; HIV ; HIV Infections/complications ; HIV Infections/epidemiology ; HIV Infections/genetics ; Humans ; Male ; Middle Aged ; Nevirapine/administration & dosage ; Retrospective Studies ; Risk Factors ; Severity of Illness Index
Czasopismo naukowe
Tytuł:
Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
Autorzy:
Salvaggio SE; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
Giacomelli A; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy. .
Falvella FS; ASST Fatebenefratelli-Sacco, Clinical Pharmacology Department, Milan, Italy.
Oreni ML; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
Meraviglia P; ASST Fatebenefratelli-Sacco, First Division of Infectious Diseases, Milan, Italy.
Atzori C; ASST Fatebenefratelli-Sacco, First Division of Infectious Diseases, Milan, Italy.
Clementi EGI; Clinical Pharmacology Unit, Consiglio Nazionale delle Ricerche Institute of Neuroscience, DIBIC Luigi Sacco - University of Milan, Milan, Italy.; E. Medea Scientific Institute, Bosisio Parini, Italy.
Galli M; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy.
Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco - University of Milan, Milan, Italy. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2017 Jun 05; Vol. 17 (1), pp. 396. Date of Electronic Publication: 2017 Jun 05.
Typ publikacji:
Journal Article; Observational Study
MeSH Terms:
Polymorphism, Single Nucleotide*
Anti-HIV Agents/*adverse effects
Kidney Diseases/*chemically induced
Kidney Diseases/*genetics
Tenofovir/*adverse effects
Adult ; Alleles ; Cohort Studies ; Female ; HIV Infections/drug therapy ; Humans ; Kidney Diseases/physiopathology ; Male ; Middle Aged ; Multidrug Resistance-Associated Protein 2 ; Multidrug Resistance-Associated Proteins/genetics ; Proteinuria/chemically induced
Czasopismo naukowe
Tytuł:
Renal function in HIV/HBV co-infected and HBV mono-infected patients on a long-term treatment with tenofovir in real life setting.
Autorzy:
Milazzo L; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Gervasoni C; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Falvella FS; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Cattaneo D; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Mazzali C; Department of Management, Economics and Industrial Engineering, Milan Politecnico, Milan, Italy.
Ronzi P; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Binda F; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Cheli S; Unit of Clinical Pharmacology, L. Sacco University Hospital, Milan, Italy.
Sollima S; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Antinori S; Department of Biomedical and Clinical Sciences L. Sacco, University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
Clinical and experimental pharmacology & physiology [Clin Exp Pharmacol Physiol] 2017 Feb; Vol. 44 (2), pp. 191-196.
Typ publikacji:
Journal Article
MeSH Terms:
Antiviral Agents/*adverse effects
HIV Infections/*physiopathology
Hepatitis B/*physiopathology
Kidney/*physiopathology
Tenofovir/*adverse effects
Adult ; Antiviral Agents/administration & dosage ; Antiviral Agents/pharmacokinetics ; Antiviral Agents/therapeutic use ; Coinfection ; Creatinine/blood ; Dose-Response Relationship, Drug ; Female ; Genotype ; Glomerular Filtration Rate/drug effects ; Glomerular Filtration Rate/genetics ; HIV Infections/drug therapy ; HIV Infections/genetics ; HIV Infections/virology ; Hepatitis B/drug therapy ; Hepatitis B/genetics ; Hepatitis B/virology ; Humans ; Kidney/metabolism ; Male ; Middle Aged ; Multidrug Resistance-Associated Protein 2 ; Multidrug Resistance-Associated Proteins/genetics ; Tenofovir/administration & dosage ; Tenofovir/pharmacokinetics ; Tenofovir/therapeutic use ; Time Factors
Czasopismo naukowe
Tytuł:
The combination of pharmacogenetic and pharmacokinetic analyses to optimize clomipramine dosing in major depression: a case report.
Autorzy:
Antoniazzi S; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan, Italy.; Scientific Direction, IRCCS Ca' Granda Maggiore Policlinico Hospital Foundation, Milan, Italy.
Tatulli A; Department of Psychiatry, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Falvella FS; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan, Italy.
Cigliobianco M; Department of Psychiatry, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Paoli RA; Department of Psychiatry, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Cattaneo D; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan, Italy.
Cheli S; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan, Italy.
Bernardi FF; Section of Pharmacology 'L. Donatelli', Department of Experimental Medicine, Faculty of Medicine and Surgery, Second University of Naples, Naples, Italy.
Clementi E; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan, Italy.; E. Medea Scientific Institute, Lecco, Italy.
Altamura CA; Department of Psychiatry, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, University of Milan, Milan, Italy.
Pokaż więcej
Źródło:
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2017 Feb; Vol. 42 (1), pp. 119-121. Date of Electronic Publication: 2016 Oct 31.
Typ publikacji:
Case Reports
MeSH Terms:
Antidepressive Agents, Tricyclic/*administration & dosage
Clomipramine/*administration & dosage
Depressive Disorder, Major/*drug therapy
Depressive Disorder, Major/genetics ; Drug Monitoring/methods ; Female ; Humans ; Middle Aged ; Pharmacogenetics/methods ; Polymorphism, Genetic/genetics
Raport
Tytuł:
The first steps towards the era of personalised vaccinology: predicting adverse reactions.
Autorzy:
Pellegrino P; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Falvella FS; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Perrone V; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Carnovale C; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Brusadelli T; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Pozzi M; Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco, Italy.
Antoniazzi S; IRCCS Foundation Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Cheli S; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Perrotta C; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Clementi E; 1] Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco, Italy [2] Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, Consiglio Nazionale delle Ricerche Institute of Neuroscience, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Radice S; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Universitá di Milano, Milan, Italy.
Pokaż więcej
Źródło:
The pharmacogenomics journal [Pharmacogenomics J] 2015 Jun; Vol. 15 (3), pp. 284-7. Date of Electronic Publication: 2014 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Drug-Related Side Effects and Adverse Reactions/*genetics
Genetic Variation/*genetics
Vaccination/*adverse effects
Vaccines/*adverse effects
Humans ; Pharmacogenetics/methods ; Risk
Czasopismo naukowe
Tytuł:
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase.
Autorzy:
Falvella FS; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan 20157, Italy. falvella..
Caporale M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Cheli S; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, University Hospital 'Luigi Sacco', Università di Milano, Milan 20157, Italy. cheli..
Martinetti A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Berenato R; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Maggi C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Ricchini F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Bossi I; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Di Bartolomeo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Sottotetti E; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Bernardi FF; Department of Experimental Medicine, Section of Pharmacology 'L. Donatelli', Faculty of Medicine and Surgery, Second University of Naples, Naples 80138, Italy. .
de Braud F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Clementi E; Scientific Institute, IRCCS E. Medea, Bosisio Parini, Lecco 23842, Italy. .; Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences, Consiglio Nazionale delle Ricerche Institute of Neuroscience, University Hospital 'Luigi Sacco', Università di Milano, Milan 20157, Italy. .
Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, Milan 20133, Italy. .
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2015 Apr 21; Vol. 16 (4), pp. 8884-95. Date of Electronic Publication: 2015 Apr 21.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Antimetabolites, Antineoplastic/*adverse effects
Dihydrouracil Dehydrogenase (NADP)/*genetics
Fluorouracil/*adverse effects
Animals ; Antimetabolites, Antineoplastic/therapeutic use ; Colorectal Neoplasms/drug therapy ; Epigenesis, Genetic ; Fluorouracil/therapeutic use ; Gene Frequency ; Humans ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł:
A 5'-region polymorphism modulates promoter activity of the tumor suppressor gene MFSD2A.
Autorzy:
Colombo F; Department of Predictive and Preventive Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
Falvella FS
Galvan A
Frullanti E
Kunitoh H
Ushijima T
Dragani TA
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2011 Jul 07; Vol. 10, pp. 81. Date of Electronic Publication: 2011 Jul 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Polymorphism, Single Nucleotide*/physiology
5' Untranslated Regions/*genetics
Promoter Regions, Genetic/*genetics
Tumor Suppressor Proteins/*genetics
5' Untranslated Regions/physiology ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/pathology ; Cell Line, Tumor ; Gene Expression Regulation, Neoplastic/physiology ; Genes, Tumor Suppressor ; Genetic Predisposition to Disease ; HEK293 Cells ; HT29 Cells ; Hep G2 Cells ; Humans ; Linkage Disequilibrium ; Lung Neoplasms/genetics ; Lung Neoplasms/pathology ; Promoter Regions, Genetic/physiology ; Symporters ; Tumor Suppressor Proteins/metabolism ; Tumor Suppressor Proteins/physiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies